We’re In! GelSana Therapeutics, Inc. Joins the 2025 MedTech Innovator Cohort
We’re proud to share that GelSana Therapeutics, Inc. has been selected to join the 2025 MedTech Innovator cohort, the world’s largest accelerator for medical device companies. GelSana is one of only 65 companies—representing the top 4% of nearly 1,500 global applicants—chosen for this year’s program. This recognition reflects the incredible work of our team and validates the potential of our solution to make a meaningful impact on healthcare. Many thanks to the mentors, investors, and reviewers who believe in our vision. Over the next few months, we’ll be participating in corporate mentorship, virtual accelerator programming (including coaching, tailored programming, and industry events) designed to accelerate our growth—and we’re excited to bring the whole team along for the journey.
About MedTech InnovatorMedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing nearly 14,000 applicants and fostering the growth of over 700 graduates. Alumni have collectively raised $10 billion in follow-on funding and introduced 400+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, and follow them on LinkedIn.